The new HRT conversation.

Make room for your symptoms

If menopause symptoms are disrupting your sleep, comfort, or everyday life, they deserve a thoughtful conversation. You do not need to arrive with a preferred prescription. Start with what is happening, how often it occurs, and what you most want help with.

Hormone therapy can relieve symptoms such as hot flashes, night sweats, and vaginal dryness, and it can help prevent bone loss. The balance of benefits and risks depends on age, timing, health history, formulation, and route. This is individualized medical care—not a universal beauty or longevity routine.

What changed in 2026

On February 12, 2026, FDA approved revised labeling for six menopausal hormone products, removing cardiovascular disease, breast cancer, and probable dementia statements from their boxed warnings. The change did not erase every risk: other labeling still addresses relevant risks, and the endometrial-cancer boxed warning remains for systemic estrogen-only products. Read the current label for the specific medicine being considered.

Understand the language

The Office on Women's Health says benefits are more likely to outweigh risks when treatment begins before 60 or within 10 years of menopause, with individual assessment. Therapy should not be used solely to prevent heart disease; whether it prevents dementia remains uncertain.

The word bioidentical can cause confusion. FDA-approved products containing hormones structurally identical to those made by the body already exist. ACOG advises that compounded bioidentical menopause therapy should not routinely replace approved formulations when those options are available. Compounded is not another word for safer.

Print your appointment questions

Bring your symptoms, medication list, and relevant medical and family history. Ask how different options compare for your particular concerns. You should leave understanding the proposed purpose, likely benefits, uncertainties, and follow-up—not simply the name of a treatment.

Nonhormonal options also belong in the discussion. If a recommendation feels rushed or the explanation does not make sense, it is reasonable to ask for more detail before deciding. An informed decision can include choosing a treatment, choosing an alternative, or taking more time.

• Which of my symptoms could this treatment help?
• How do my health history and menopause timing affect the decision?
• Would local or systemic treatment fit my symptoms?
• Is the proposed product FDA-approved, and why is it being chosen?
• What alternatives should I consider?
• What changes should I report, and when will we review treatment?